Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Oric Pharmaceuticals, Inc. | d843476ds1a.htm |
| EX-5.1 - EX-5.1 - Oric Pharmaceuticals, Inc. | d843476dex51.htm |
| EX-3.1 - EX-3.1 - Oric Pharmaceuticals, Inc. | d843476dex31.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
ORIC Pharmaceuticals, Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Diego, California
April 23, 2020